Which urine laboratory tests should be ordered to evaluate acute kidney injury?

Urine Laboratory Tests for AKI Workup

Order a urinalysis with microscopy, urine sodium, and urine creatinine as your core panel, with consideration of novel biomarkers (NGAL, TIMP-2×IGFBP7) in high-risk patients where available.

Essential Basic Tests

The fundamental urine workup should include:

• Urinalysis with manual microscopy - This remains the cornerstone diagnostic tool despite automation 1. Manual microscopy specifically looking for casts and renal tubular epithelial cells (RTEC) is highly predictive of acute tubular necrosis (ATN). A scoring system where any casts or RTEC (score ≥2) has very high positive predictive value for ATN in patients with high pretest probability, while absence of these elements has 91% negative predictive value for prerenal AKI 1.

• Urine sodium (UNa) - Shows >85% specificity for differentiating prerenal AKI from intrarenal causes 2. This parameter is not confounded by loop diuretics, ACE inhibitors/ARBs, or pre-existing CKD 2.

• Urine specific gravity (USG) - Demonstrates >85% specificity for prerenal AKI and can be easily obtained from spot urine 2.

• Spot urine creatinine - Needed to calculate the fractional excretion of sodium (FENa) and the urine creatinine-to-plasma creatinine ratio (UCr/PCr) 3, 4.

Calculated Indices from Basic Tests

From the above basic tests, calculate:

• Fractional Excretion of Sodium (FENa) - Traditional marker for prerenal vs. intrarenal differentiation 4
• Renal Failure Index (RFI) - Provides good specificity for both prerenal AKI and ATN 2
• Urine creatinine-to-osmolality ratio (sUCr/Osm) - With cutoff of 8.84 shows 88% sensitivity for predicting renal recovery 5

Advanced Biomarkers (When Available)

For risk stratification and early detection, particularly in critically ill patients:

• Urine NGAL (neutrophil gelatinase-associated lipocalin) - Patients with elevated uNGAL without increased serum creatinine have 4-fold increased risk of developing AKI, and those with both elevated have 12-fold increased risk of progressing to stage 2-3 AKI 6.

• TIMP-2 × IGFBP7 - Values >2.0 (ng/mL)²/1000 predict AKI progression and are equivalent to actual AKI progression even when serum creatinine doesn't progress from stage 1 6. This combination assists in therapy planning and management 6.

Critical Pitfalls to Avoid

Volume status confounding: Serum creatinine concentrations are affected by hydration status - significant volume expansion can cause dilutional effects that mask true GFR reduction 3. This is why urine indices are particularly valuable.

Relying solely on automated urinalysis: Manual microscopy adds critical diagnostic information that automated systems miss, particularly in identifying casts and cellular elements 7. The presence or absence of granular casts, muddy brown casts, and RTEC fundamentally changes diagnostic probability.

Ignoring medication effects: While UNa, USG, and RFI are not significantly affected by common medications 2, be aware that FENa can be altered by diuretics. In diuretic-treated patients, fractional excretion of urea (FEUrea) may be more reliable 4.

Algorithmic Approach

1. Immediate: Obtain urinalysis with manual microscopy + spot urine for sodium and creatinine
2. Calculate: FENa, RFI, and UCr/PCr from spot urine and concurrent serum values
3. Interpret microscopy: Score based on casts/RTEC presence (≥2 = high probability ATN; 0-1 = consider prerenal)
4. Risk stratify: If available and patient is critically ill or post-cardiac surgery, add NGAL or TIMP-2×IGFBP7 for progression risk 6
5. Sequential monitoring: Repeat urine biochemistry assessment serially, as single time-point measurements have limitations 8

The KDIGO guidelines emphasize that determining the cause of AKI should be pursued whenever possible 3, and this simple panel of readily available urine tests provides the diagnostic framework to differentiate prerenal from intrarenal causes while identifying those at highest risk for progression.